跳至主要内容
临床试验/NCT07075627
NCT07075627撤回不适用

An Observational Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

Addario Lung Cancer Medical Institute1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
不适用
状态
撤回
入组人数
400
试验地点
1
主要终点
Suspicious LEMS

研究概览

简要总结

This is a multi-center observational study in subjects with a diagnosis of small cell lung cancer. Screening and/or medical record review for symptoms associated with Lambert Eaton Myasthenic Syndrome (LEMS) will be conducted.

详细描述

This is a multi-center observational study in subjects with a diagnosis of small cell lung cancer. All eligible subjects enrolled will undergo a brief, symptom directed neurological evaluation and VGCC antibody testing (to be performed at a participating Quest laboratory). The results (positive/negative) of VGCC antibody testing will be documented as well as the receptor type P, Q or N.

These tests will be repeated quarterly (Q3 months) for the duration of the study.

If at any visit the subject is found to be BOTH neurologically suggestive of having LEMS and the VGCC Ab test is positive, then the subject is considered to be Clinically Suspicious of having LEMS. At any visit if a subject meets the criteria of Clinically Suspicious of LEMS. the end of study visit will be completed. Once the End of study visit is completed no further treatment information will be collected.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult men or women meeting Age of Majority (AOM) at the time of consent
  • Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF)
  • Any diagnosis of SCLC
  • Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required
  • Willing to comply with the requirements of the study

排除标准

  • Has been diagnosed with non-tumor Lamber-Eaton Myasthenic syndrome (LEMS) > 1 year prior to the SCLC diagnosis.
  • Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements

结局指标

主要结局

Suspicious LEMS

时间窗: 1 year

Incidence of clinically suspicious LEMS diagnosis

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验